by 
Legionella testing involves the detection of Legionella bacteria that causes Legionnaires’ disease, a severe form of pneumonia. Legionella testing kits are used to detect the presence of Legionella bacteria in water samples collected from places prone to Legionella growth such as cooling towers, hot tubs, fountains, and large plumbing systems. The global Legionella testing market offers immunochromatographic kits, direct fluorescent antibody (DFA) kits, enzyme-linked immunosorbent assay (ELISA) kits, polymerase chain reaction (PCR) kits, and culture media kits for Legionella testing. Wide applications of Legionella testing include testing of potable water systems, cooling towers, whirlpool spas, and respiratory samples to diagnose Legionnaires’ disease and limit Legionella outbreaks.
The global Legionella testing market is estimated to be valued at US$ 1,864.07 million in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Increasing prevalence of Legionellosis is expected to drive the global Legionella testing market over the forecast period. According to the Centers for Disease Control and Prevention (CDC), around 8,000 to 18,000 people in the United States get Legionnaires’ disease each year. Legionella infection causes Pontiac fever and Legionnaires’ disease, with Legionnaires’ disease being a more serious type of pneumonia. The disease is especially fatal in individuals with weak immunity. Furthermore, rising adoption of Legionella testing as a standard procedure by hospitals, healthcare facilities, and municipalities due to mandatory regulations is expected to boost market growth. For instance, European Standard EN ISO 11731 requires testing and monitoring of Legionella in water systems responsible for producing or distributing hot and cold water that is likely to pose a health risk if contaminated by the bacteria.
Segment Analysis
The global Legionella testing market is dominated by two major segments namely laboratory tests and kits & reagents. The laboratory tests segment accounts for over 60% of market share in 2023 on account of higher accuracy of results along with advantages like specificity and sensitivity offered by laboratory testing. Also, the laboratory tests segment is expected to witness higher growth during the forecast period owing to the ability to test multiple samples simultaneously in laboratories.
PEST Analysis
Political: Public health agencies across regions have implemented stringent regulations mandating regular monitoring and testing of water systems prone to Legionella contamination. This is positively impacting market growth.
Economic: Increasing healthcare expenditures along with growing economic prosperity in developing nations is augmenting demand for advanced Legionella testing products and services.
Social: Rising public awareness about waterborne diseases coupled with global initiatives to curb Legionella outbreaks is driving the adoption of Legionella testing solutions.
Technological: Continuous R&D efforts by market players towards developing rapid, user-friendly and advanced Legionella testing kits and reagents is further expanding the market scope.
Key Takeaways
The global Legionella testing market is expected to witness high growth at a CAGR of 7.8% during the forecast period.
Regional analysis: The North America Legionella testing market is the largest globally, accounting for over 35% share in 2023. This is attributed to factors such as presence of major market players, rapid technological adoption, supportive regulatory guidelines for mandatory testing, and increasing healthcare expenditure. Asia Pacific is poised to witness fastest growth during the forecast period supported by growing medical tourism, improving healthcare infrastructure, and rising incidence of Legionnaires’ disease in densely populated regions.
Key players: Key players operating in the Legionella testing market are Boston Scientific Corporation, Argon Medical Devices, Inc., Becton, Dickinson and Company, Cook Medical, B. Braun Melsungen AG, Medtronic Plc., Novo Nordisk A/S, SERAG-WIESSNER GmbH & Co., Smithâ€TMs Medical, Terumo Corporation, Stryker Corporation, and NIPRO Medical Corporation. Major players are focusing on new product launches and geographic expansion to strengthen their market presence.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
